Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA4 | P22748 | 2/20 | 0.41 |
| ▸ | CA6 | P23280 | 2/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10495935 | 0.82 | ALDH1A1 (0.46) | CA1CA2PTPN1CYP3A4TSHR | |
| Tribromometacresol SCHEMBL467297 | 0.78 | CA1 (0.52) | CA1CA2CA4CA6PTPN1 | |
| Tribromometacresol SCHEMBL30255705 | 0.78 | CA1 (0.52) | CA1CA2CA4CA6PTPN1 | |
| SCHEMBL11131454 | 0.76 | MAPT (0.42) | CA1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL12192916 | 0.75 | GABRA1 (0.50) | CA1CA2CYP3A4TSHRALDH1A1 | |
| SCHEMBL9478468 | 0.71 | CA1 (0.35) | CA1CA2CA4CA6PTPN1 | |
| SCHEMBL17744522 | 0.70 | ALDH1A1 (0.60) | CA1CA2CA4CA6CYP3A4 | |
| SCHEMBL17744621 | 0.70 | CD44 (0.41) | CA1CA2CA4CA6CYP3A4 | |
| SCHEMBL9166780 | 0.70 | ALOX5 (0.44) | CA1CA2CA4CA6PTPN1 | |
| SCHEMBL10824898 | 0.69 | CA1 (0.52) | CA1CA2CA4CA6CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9745336-B2 | Fluorescent dye compounds, conjugates and uses thereof | APPLIED BIOSYSTEMS, LLC (US) | 2017-08-29 | — | — | US | disclosed |
| US-9745336-B2 | Fluorescent dye compounds, conjugates and uses thereof | APPLIED BIOSYSTEMS, LLC (US) | 2017-08-29 | — | — | US | disclosed |
| US-20140303003-A1 | Fluorescent Dye Compounds, Conjugates and Uses Thereof | APPLIED BIOSYSTEMS, LLC (US) | 2014-10-09 | — | — | US | disclosed |
| US-20140303003-A1 | Fluorescent Dye Compounds, Conjugates and Uses Thereof | APPLIED BIOSYSTEMS, LLC (US) | 2014-10-09 | — | — | US | disclosed |
| US-8729267-B2 | Fluorescent dye compounds, conjugates and uses thereof | APPLIED BIOSYSTEMS, LLC (US) | 2014-05-20 | — | — | US | disclosed |
| US-8729267-B2 | Fluorescent dye compounds, conjugates and uses thereof | APPLIED BIOSYSTEMS, LLC (US) | 2014-05-20 | — | — | US | disclosed |
| US-20110250699-A1 | Fluorescent Dye Compounds, Conjugates and Uses Thereof | Life Technologies Corporation (US) | 2011-10-13 | — | — | US | disclosed |
| US-20110250699-A1 | Fluorescent Dye Compounds, Conjugates and Uses Thereof | Life Technologies Corporation (US) | 2011-10-13 | — | — | US | disclosed |
| EP-2371927-A1 | Fluorescent dye compounds, conjugates and uses thereof | Life Technologies Corporation (US) | 2011-10-05 | — | — | EP | disclosed |
| US-7985602-B2 | Fluorescent dye compounds, conjugates and uses thereof | APPLIED BIOSYSTEMS, LLC (US) | 2011-07-26 | — | — | US | disclosed |
| EP-0317243-B1 | Method and test composition for determination of enzyme activity | KYOWA MEDEX CO LTD (JP) | 1994-08-31 | — | — | EP | disclosed |
| US-5223404-A | Chromogen, oxidase, compound which releases rate enhancer in presence of peptidase | SUNSTAR KABUSHIKI KAISHA (JP) | 1993-06-29 | — | — | US | disclosed |
| EP-0325472-B1 | COMPOSITION FOR TESTING PERIODONTAL DISEASES | SUNSTAR KABUSHIKI KAISHA (JP) | 1993-04-28 | — | — | EP | disclosed |
| US-5196312-A | Coloeimetric analysis, aniline promoter | KYOWA MEDEX COMPANY, LTD. (JP) | 1993-03-23 | — | — | US | disclosed |
| EP-0325472-A2 | Composition for testing periodontal diseases | SUNSTAR KABUSHIKI KAISHA (JP) | 1989-07-26 | — | — | EP | disclosed |
| EP-0317243-A2 | Method and test composition for determination of enzyme activity | Kyowa Medex Co. Ltd. (JP) | 1989-05-24 | — | — | EP | disclosed |
| US-4752547-A | RECORDING LAYER CONTAINS REDUCING AGENT, LEWIS BASE COMPLEX, AND REDUCIBLE DYE FORMING COMPOUND | EASTMAN KODAK COMPANY (US) | 1988-06-21 | — | — | US | disclosed |
| US-4727008-A | MULTILAYER-IMAGEWISE EXPOSURE TO ELECTRICAL CHARGES OF DIFFERENT POLARITIES TO GIVE DEVELOPABLE IMAGES | EASTMAN KODAK COMPANY (US) | 1988-02-23 | — | — | US | disclosed |
| EP-0251761-A2 | Multicolor laser recording method and element | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-01-07 | — | — | EP | disclosed |
| US-4684602-A | Multicolor laser recording method and element | EASTMAN KODAK COMPANY (US) | 1987-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110250699-A1 | Fluorescent Dye Compounds, Conjugates and Uses Thereof | GFPT1, SLC46A1, SLC7A5 | CA1 2552/4885CA2 3340/4885CA4 1283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.